A homozygous missense variant, p.Ser166Leu in the PRPF40B gene, in a 7.7 Mb region of homozygosity in a consanguineous Turkish family with essential tremor - Scorecard - MDSpire

A homozygous missense variant, p.Ser166Leu in the PRPF40B gene, in a 7.7 Mb region of homozygosity in a consanguineous Turkish family with essential tremor

  • By

  • Onur Emre Onat

  • Shilpa Sonti

  • Daphne Robakis

  • Ayse B. Tekinay

  • Cenk Akbostanci

  • F. Nazli Durmaz Celik

  • Tayfun Ozcelik

  • Lorraine N. Clark

  • May 26, 2026

  • 0 min

Share

Clinical Scorecard: Identification of a homozygous missense mutation, p.Ser166Leu, in the PRPF40B gene within a 7.7 Mb homozygous region in a consanguineous family from Turkey with essential tremor

At a Glance

CategoryDetail
ConditionEssential Tremor (ET)
Key MechanismsHomozygous missense variant in PRPF40B gene
Target PopulationConsanguineous Turkish family
Care SettingClinical evaluation at Ankara University Medical School and Bilkent University

Key Highlights

  • Identification of PRPF40B missense variant p.Ser166Leu in affected family members
  • ET prevalence in Turkey ranges from 1.6% to 4% in different regions
  • Consanguinity facilitated genetic discovery in the Turkish population

Guideline-Based Recommendations

Diagnosis

  • Use Washington-Heights-Inwood Genetic Study of ET criteria for diagnosis

Management

  • Clinical assessment of tremor severity and associated symptoms

Monitoring & Follow-up

  • Regular evaluation for features of Parkinson's Disease and other neurological symptoms

Risks

  • Increased risk of neurological disorders in consanguineous populations

Patient & Prescribing Data

Individuals from a consanguineous Turkish family with ET

Genetic analysis suggests potential for targeted therapies based on PRPF40B variant

Clinical Best Practices

  • Conduct thorough clinical assessments for tremor and associated symptoms
  • Utilize genetic testing for familial cases of ET

Related Resources & Content

Original Source(s)

Related Content